TOP HEADLINES

Featured Story

Recipharm trades $140M for a Portuguese CDMO

Pharma outsourcer Recipharm has acquired a Portuguese contract drug developer for €112.3 million ($140 million) in cash and stock, bolstering its global scale and further consolidating the world of R&D service providers.

Parexel eyes logistics with latest EU expansion

Parexel International has cut the ribbon on a new clinical trial supply hub in Europe, centralizing the CRO's continental logistics services as part of a companywide effort to more efficiently conduct studies around the globe.

Catalent makes another buy and ticks up its revenue

Catalent has acquired another R&D tech firm, snapping up Micron Technologies and its particle sizing capabilities as the recently IPO'd company works to expand its share of the drug development market.

WuXi ups its revenue ambitions after M&A and expansion

Chinese CRO WuXi PharmaTech is forecasting a better-than-expected 2014 after a strong third quarter and some timely deals, moving into the new year with hopes for continued global growth.

Charles River deepens its ties to Huntington's R&D with new deal

Charles River Laboratories has extended its partnership with CHDI Foundation, signing up for 5 more years of work spotlighting new treatments for Huntington's disease.

MORE NEWS

From Our Sister Sites

FierceDiagnostics

LabCorp and CareDx have officially pulled the plug on a previously announced agreement to develop a lupus flare predictor test after completing the first phase of their collaboration.

FierceAnimalHealth

A U.K. consortium led by Zoetis announced a $3 million project that will use visual imaging and digital technology to improve the health and wellness of pig herds with a goal of better production.